Literature DB >> 19391654

Morphogenomics and morphoproteomics: a role for anatomic pathology in personalized medicine.

Robert E Brown1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19391654     DOI： 10.5858/133.4.568

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  23 in total

Review 1.  Integrative analysis of -omics data and histologic scoring in renal disease and transplantation: renal histogenomics.

Authors:  Paul Perco; Rainer Oberbauer
Journal:  Semin Nephrol       Date:  2010-09       Impact factor: 5.299

2.  Data driven linear algebraic methods for analysis of molecular pathways: application to disease progression in shock/trauma.

Authors:  Mary F McGuire; M Sriram Iyengar; David W Mercer
Journal:  J Biomed Inform       Date:  2011-12-17       Impact factor: 6.317

3.  Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.

Authors:  Andrés E Quesada; Binara Assylbekova; Christine E Jabcuga; Rongzhen Zhang; Michael Covinsky; Adan Rios; Nghia D Nguyen; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma.

Authors:  Qi Shen; Melissa L Stanton; Wei Feng; Michelle E Rodriguez; Lois Ramondetta; Lei Chen; Robert E Brown; Xiuzhen Duan
Journal:  Int J Clin Exp Pathol       Date:  2010-11-20

5.  Persistent hyperinsulinemic hypoglycemia of infancy: constitutive activation of the mTOR pathway with associated exocrine-islet transdifferentiation and therapeutic implications.

Authors:  Sanda Alexandrescu; Nina Tatevian; Oluyinka Olutoye; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2010-08-08

6.  Antitumor Response to Combined Antiangiogenic and Cytotoxic Chemotherapy in Recurrent Metastatic Chromophobe Renal Cell Carcinoma: Response Signatures and Proteomic Correlates.

Authors:  Abhishek Maiti; Robert E Brown; Paul G Corn; Ravi Murthy; Dhakshina Moorthy Ganeshan; Apostolia M Tsimberidou; Vivek Subbiah
Journal:  Clin Genitourin Cancer       Date:  2015-11-11       Impact factor: 2.872

7.  Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.

Authors:  Jing Liu; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2010-10-01

8.  Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications.

Authors:  Sadhna Dhingra; Michelle E Rodriguez; Qi Shen; Xuizhen Duan; Melissa L Stanton; Lei Chen; Rongzhen Zhang; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2010-01-28

9.  Ewing's sarcoma: overcoming the therapeutic plateau.

Authors:  Vivek Subbiah; Razelle Kurzrock
Journal:  Discov Med       Date:  2012-06       Impact factor: 2.970

10.  Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.

Authors:  Sanda Alexandrescu; Nina Tatevian; Bogdan A Czerniak; Michael H Covinsky; Nadja K Burns; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2012-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.